Literature DB >> 9122710

Coreceptors: implications for HIV pathogenesis and therapy.

J P Moore1.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9122710     DOI： 10.1126/science.276.5309.51

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  53 in total

1.  Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits.

Authors:  R W Sanders; L Schiffner; A Master; F Kajumo; Y Guo; T Dragic; J P Moore; J M Binley
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus.

Authors:  P D Kwong; R Wyatt; Q J Sattentau; J Sodroski; W A Hendrickson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Inhibition of HIV-1-mediated syncytium formation and virus replication by the lipophosphoglycan from Leishmania donovani is due to an effect on early events in the virus life cycle.

Authors:  N Genois; B Barbeau; M Olivier; M J Tremblay
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

4.  T cell signaling mechanisms that regulate HIV-1 infection.

Authors:  D Unutmaz
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

5.  Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health.

Authors:  Sanaa M Kamal; Louise Warnich; Lynnette R Ferguson; Sanjeeva Srivastava; Sandipan Ray; Denise Avard; Yann Joly; Michael Le Huynh; Madeline Page; Mario Masellis; Edward S Dove; David Gurwitz; Vural Ozdemir
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-09-01

Review 6.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

7.  Stabilization of HIV-1 envelope in the CD4-bound conformation through specific cross-linking of a CD4 mimetic.

Authors:  Grégoire Martin; Brian Burke; Robert Thaï; Antu K Dey; Olivier Combes; Oscar H P Ramos; Bernadette Heyd; Anthony R Geonnotti; David C Montefiori; Elaine Kan; Ying Lian; Yide Sun; Toufik Abache; Jeffrey B Ulmer; Hocine Madaoui; Raphaël Guérois; Susan W Barnett; Indresh K Srivastava; Pascal Kessler; Loïc Martin
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

8.  Engineered lentiviral vectors pseudotyped with a CD4 receptor and a fusogenic protein can target cells expressing HIV-1 envelope proteins.

Authors:  Chi-Lin Lee; Jason Dang; Kye-Il Joo; Pin Wang
Journal:  Virus Res       Date:  2011-07-23       Impact factor: 3.303

Review 9.  NKT cell immune responses to viral infection.

Authors:  Marlowe S Tessmer; Ayesha Fatima; Christophe Paget; Francois Trottein; Laurent Brossay
Journal:  Expert Opin Ther Targets       Date:  2009-02       Impact factor: 6.902

10.  Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics.

Authors:  Kara G Lassen; Michael A Lobritz; Justin R Bailey; Samantha Johnston; Sandra Nguyen; Benhur Lee; Tom Chou; Robert F Siliciano; Martin Markowitz; Eric J Arts
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.